BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
-22.5%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
+$262M
(-26%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
5.34%
Top 10 Holdings %
Top 10 Hldgs %
66.42%
Holding
56
New
11
Increased
5
Reduced
31
Closed
1
Top Buys
| 1 |
Amazon
AMZN
|
$15.5M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$726K |
| 3 |
UroGen Pharma
URGN
|
$337K |
| 4 |
Evolus
EOLS
|
$291K |
| 5 |
Visa
V
|
$221K |
Top Sells
| 1 |
Apple
AAPL
|
$562K |
| 2 |
Idexx Laboratories
IDXX
|
$268K |
| 3 |
Mercado Libre
MELI
|
$243K |
| 4 |
Alphabet (Google) Class C
GOOG
|
$232K |
| 5 |
VMW
VMware, Inc
VMW
|
$217K |
Sector Composition
| 1 | Technology | 38.9% |
| 2 | Consumer Discretionary | 25.33% |
| 3 | Healthcare | 21.63% |
| 4 | Communication Services | 11.08% |
| 5 | Utilities | 1.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$140B
| $2.32M | 0.89% |
37,600
-2,107
| -5% | -$130K |
|
27
Bristol-Myers Squibb
BMY
$96B
| $1.93M | 0.74% |
25,062
-300
| -1% | -$23.1K |
|
28
Advanced Micro Devices
AMD
$264B
| $1.48M | 0.56% |
19,288
+1,355
| +8% | +$104K |
|
29
Cognizant
CTSH
$35.3B
| $1.28M | 0.49% |
18,898
-465
| -2% | -$31.4K |
|
30
Pfizer
PFE
$141B
| $1.01M | 0.38% |
19,180
| – | – |
|
31
Abbott
ABT
$231B
| $946K | 0.36% |
8,706
-35
| -0.4% | -$3.8K |
|
32
Johnson & Johnson
JNJ
$427B
| $907K | 0.35% |
5,107
| – | – |
|
33
Costco
COST
$418B
| $902K | 0.34% |
1,883
| – | – |
|
34
Paychex
PAYX
$50.2B
| $826K | 0.32% |
7,250
| – | – |
|
35
Norfolk Southern
NSC
$62.8B
| $782K | 0.3% |
3,441
-345
| -9% | -$78.4K |
|
|
36
BioCryst Pharmaceuticals
BCRX
$1.74B
| $726K | 0.28% |
+68,600
| New | +$726K |
|
37
Merck
MRK
$210B
| $703K | 0.27% |
7,712
| – | – |
|
38
Deere & Co
DE
$129B
| $467K | 0.18% |
1,561
| – | – |
|
39
JPMorgan Chase
JPM
$829B
| $466K | 0.18% |
4,134
-220
| -5% | -$24.8K |
|
40
Nucor
NUE
$34.1B
| $440K | 0.17% |
4,215
| – | – |
|
41
Boeing
BA
$177B
| $402K | 0.15% |
2,940
-483
| -14% | -$66K |
|
|
42
UroGen Pharma
URGN
$900M
| $337K | 0.13% |
+41,131
| New | +$337K |
|
43
Target
TGT
$43.6B
| $297K | 0.11% |
2,100
-140
| -6% | -$19.8K |
|
|
44
Evolus
EOLS
$494M
| $291K | 0.11% |
+25,070
| New | +$291K |
|
45
Caterpillar
CAT
$196B
| $289K | 0.11% |
1,617
-55
| -3% | -$9.83K |
|
46
Duke Energy
DUK
$95.3B
| $282K | 0.11% |
2,626
| – | – |
|
47
T Rowe Price
TROW
$23.6B
| $243K | 0.09% |
2,135
-300
| -12% | -$34.1K |
|
|
48
Visa
V
$683B
| $221K | 0.08% |
+1,120
| New | +$221K |
|
49
American Electric Power
AEP
$59.4B
| $206K | 0.08% |
+2,150
| New | +$206K |
|
|
BBIG
50
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $110K | 0.04% |
+80,000
| New | +$110K |
|